| 6 | 1/1 | 返回列表 |
| 查看: 1899 | 回復(fù): 5 | |||||
令狐沖?坌⌒?/a>至尊木蟲(chóng) (知名作家)
魔道圣君
|
[交流]
【2015年FDA批準(zhǔn)新藥匯總】 已有4人參與
|
|
FDA Approved new Drugs in 2015 date time:2015-2-10 Cardiology/Vascular Diseases Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Dermatology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Endocrinology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Family Medicine Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Hematology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Immunology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Infections and Infectious Diseases Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Neurology Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015 Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015 Obstetrics/Gynecology (Women’s Health) Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Oncology Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Pediatrics/Neonatology Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Vaccines Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 |
顓頊藥學(xué) | 偶的 |

木蟲(chóng) (正式寫(xiě)手)
超級(jí)版主 (文學(xué)泰斗)
小木蟲(chóng)科研大使\(^o^)/~

至尊木蟲(chóng) (著名寫(xiě)手)
孩他爹

金蟲(chóng) (正式寫(xiě)手)
至尊木蟲(chóng) (知名作家)
魔道圣君

| 6 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 081700化工學(xué)碩調(diào)劑 +3 | 【1】 2026-03-16 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 0703化學(xué)調(diào)劑 +10 | 妮妮ninicgb 2026-03-15 | 14/700 |
|
|
[考研] 0703化學(xué)調(diào)劑 ,六級(jí)已過(guò),有科研經(jīng)歷 +12 | 曦熙兮 2026-03-15 | 12/600 |
|
|
[考研] 一志愿南京理工大學(xué)085701資源與環(huán)境302分求調(diào)劑 +3 | 葵梓衛(wèi)隊(duì) 2026-03-18 | 5/250 |
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 6/300 |
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | 18889395102 2026-03-18 | 4/200 |
|
|
[考研] 一志愿天大材料與化工(085600)總分338 +5 | 蔡大美女 2026-03-13 | 5/250 |
|
|
[考研] 本科鄭州大學(xué)物理學(xué)院,一志愿華科070200學(xué)碩,346求調(diào)劑 +4 | 我不是一根蔥 2026-03-18 | 4/200 |
|
|
[考研] 材料工程專(zhuān)碩調(diào)劑 +5 | 204818@lcx 2026-03-17 | 6/300 |
|
|
[考研] 085410人工智能專(zhuān)碩317求調(diào)劑(0854都可以) +3 | xbxudjdn 2026-03-18 | 3/150 |
|
|
[考研] 材料專(zhuān)業(yè)求調(diào)劑 +5 | hanamiko 2026-03-18 | 5/250 |
|
|
[考研] 295求調(diào)劑 +3 | 一志愿京區(qū)211 2026-03-18 | 5/250 |
|
|
[考研] 304求調(diào)劑 +12 | 小熊joy 2026-03-14 | 13/650 |
|
|
[考研] 085601求調(diào)劑 +4 | Du.11 2026-03-16 | 4/200 |
|
|
[考研] 材料工程專(zhuān)碩274一志愿211求調(diào)劑 +6 | 薛云鵬 2026-03-15 | 6/300 |
|
|
[考研] 0854控制工程 359求調(diào)劑 可跨專(zhuān)業(yè) +3 | 626776879 2026-03-14 | 9/450 |
|
|
[考研] 277材料科學(xué)與工程080500求調(diào)劑 +3 | 自由煎餅果子 2026-03-16 | 3/150 |
|
|
[考研] 0703化學(xué)調(diào)劑 290分有科研經(jīng)歷,論文在投 +7 | 膩膩gk 2026-03-14 | 7/350 |
|
|
[考研] 0856專(zhuān)碩279求調(diào)劑 +5 | 加油加油!? 2026-03-15 | 5/250 |
|
|
[考研] 288求調(diào)劑 +4 | 奇點(diǎn)0314 2026-03-14 | 4/200 |
|